French hospital federations, including Unicancer, the French Hospital Federation, and the Private Hospital Federation (FHP), are calling for a 3.9% increase in the hospital Ondam, a funding mechanism that determines how much public money is allocated to hospitals. Part of this increase, 0.7%, is specifically intended to compensate hospitals for the rising contributions they must pay to the National Retirement Fund for Local Government Employees (CNRACL). This fund supports the pensions of local government workers, and the increase in contributions has placed additional financial pressure on hospitals. Unicancer is also pushing for progress on two key issues: the reform of how interventional radiology procedures are priced and the transition to a new system for categorizing molecular biology procedures. These changes are seen as essential for modernizing healthcare delivery and ensuring fair reimbursement for medical services. Interventional radiology involves minimally invasive procedures guided by imaging, while molecular biology procedures relate to genetic and biochemical testing used in diagnosing and treating diseases. Sophie Beaupère, Unicancer’s general delegate, is playing a central role in these efforts. She is working to ensure that hospitals have the resources and support they need to continue providing high-quality care while adapting to evolving medical practices and financial constraints. Her involvement highlights the importance of collaboration between hospital organizations and policymakers in shaping the future of healthcare in France. The push for these changes comes at a time when French hospitals are facing increasing demands on their resources, from rising patient numbers to the need for advanced medical technologies. The proposed adjustments to funding and procedures aim to address these challenges by aligning financial support with the realities of modern healthcare.